跳至主要内容
临床试验/ACTRN12624000470594
ACTRN12624000470594尚未招募Unknown

Type 1 Diabetes National Screening Pilot: Evaluating the Feasibility and Acceptability of Monitoring Children with Early Stage Type 1 Diabetes

The University of Sydney0 个研究点目标入组 36 人开始时间: 2024年4月16日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
1 Years 至 o limit(—)
性别
All

入选标准

  • Children recruited from the Childhood Type 1 Diabetes National Screening Pilot Feasibility and Acceptability Study’, ACTRN12622000381785 with
  • - Pre-type 1 diabetes (defined as a single type 1 diabetes antibody) OR
  • - Early stage type 1 diabetes (defined as multiple type 1 diabetes antibodies, not requiring insulin).
  • - Parents of children with early stage or pre-type 1 diabetes in order to complete surveys

排除标准

  • Presence of stage 3 type 1 diabetes at the time of recruitment
  • Type 2 diabetes

研究者

相似试验

尚未招募
3 期
To evaluate the safety and efficacy of orally administered supplement SJ29 Capsule in sickle cell anemia patients
CTRI/2024/07/070723Athulya Ayurvedic Medical Research Centre
已完成
1 期
A phase I, single-centre, open study to assess the pharmacokinetic profile and safety of a 100 mg Clindamycin Hydrochloride Vaginal Insert (CHVI) in healthy femalesAcute vaginitisBacterial vaginosisUrological and Genital Diseases
ISRCTN15152571Controlled Therapeutics (Scotland) Ltd (UK)10
已完成
不适用
The clinical pilot study for the evaluation of the efficacy and safety of Monascus-fermentation (Monascus-fermented black bean) on reducing body weight and serum total cholesterol obese subjects
KCT0001040Inje University Seoul Paik Hospital30
尚未招募
1 期
A single-centre, open-label, phase I study to evaluate the diagnostic performance of 89Zirconium-labelled girentuximab (89Zr-TLX250) Position Emission Tomography (PET) in Urothelial Cancer PatientsMetastatic urothelial carcinomaCancer - BladderBladder cancer
ACTRN12621000411842South Metropolitan Health Services20
进行中(未招募)
1 期
A pilot study to assess the efficacy and safety of CBD oral solution in addition to standard treatment for pediatric subjects with Developmental and Epileptic EncephalopathyDevelopmental and Epileptic Encephalopathy (DEE)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disorders
EUCTR2019-001633-14-ITIRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA20